1. Home
  2. TVRD vs RMM Comparison

TVRD vs RMM Comparison

Compare TVRD & RMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVRD
  • RMM
  • Stock Information
  • Founded
  • TVRD 2017
  • RMM 2019
  • Country
  • TVRD United States
  • RMM United States
  • Employees
  • TVRD N/A
  • RMM N/A
  • Industry
  • TVRD Biotechnology: Pharmaceutical Preparations
  • RMM Trusts Except Educational Religious and Charitable
  • Sector
  • TVRD Health Care
  • RMM Finance
  • Exchange
  • TVRD Nasdaq
  • RMM Nasdaq
  • Market Cap
  • TVRD 246.5M
  • RMM 271.2M
  • IPO Year
  • TVRD N/A
  • RMM N/A
  • Fundamental
  • Price
  • TVRD $28.98
  • RMM $13.68
  • Analyst Decision
  • TVRD Strong Buy
  • RMM
  • Analyst Count
  • TVRD 2
  • RMM 0
  • Target Price
  • TVRD $52.00
  • RMM N/A
  • AVG Volume (30 Days)
  • TVRD 48.4K
  • RMM 66.5K
  • Earning Date
  • TVRD 05-13-2025
  • RMM 01-01-0001
  • Dividend Yield
  • TVRD N/A
  • RMM 7.33%
  • EPS Growth
  • TVRD N/A
  • RMM N/A
  • EPS
  • TVRD N/A
  • RMM 0.96
  • Revenue
  • TVRD N/A
  • RMM N/A
  • Revenue This Year
  • TVRD N/A
  • RMM N/A
  • Revenue Next Year
  • TVRD N/A
  • RMM N/A
  • P/E Ratio
  • TVRD N/A
  • RMM $15.55
  • Revenue Growth
  • TVRD N/A
  • RMM N/A
  • 52 Week Low
  • TVRD $8.13
  • RMM $12.32
  • 52 Week High
  • TVRD $34.31
  • RMM $16.10
  • Technical
  • Relative Strength Index (RSI)
  • TVRD N/A
  • RMM 46.06
  • Support Level
  • TVRD N/A
  • RMM $13.51
  • Resistance Level
  • TVRD N/A
  • RMM $13.85
  • Average True Range (ATR)
  • TVRD 0.00
  • RMM 0.16
  • MACD
  • TVRD 0.00
  • RMM -0.02
  • Stochastic Oscillator
  • TVRD 0.00
  • RMM 28.68

About TVRD Tvardi Therapeutics Inc. Common Stock

Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.

About RMM RiverNorth Managed Duration Municipal Income Fund Inc.

RiverNorth Managed Duration Muni Inc Fd is a United States based diversified, closed-end management investment company. Its primary investment objective is current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.

Share on Social Networks: